Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOte Ads Regulatory News (OTES)

Share Price Information for Ote Ads (OTES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.06274
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 6.06274
High: 0.00
Low: 0.00
Prev. Close: 6.06274
OTES Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to the HCMC EU's approval of TKR disposal

30 Jul 2021 09:21

RNS Number : 0665H
Hellenic Telecomms Organization S A
30 July 2021
 

Response to

Hellenic Capital Market Commission letter

 

Athens, July 30, 2021 - Hellenic Telecommunications Organization S.A. ("OTE S.A." or the "Company"), following its announcement on 28.7.2021 and in response to the Hellenic Capital Market Commission relevant request for clarifications, dated 29-07-2021, on European Commission's (EC) conditional approval for the sale of Telekom Romania Communications S.A. ("TKR") to Orange, announces the following:

 

1) Following its investigation, the EC as it mentions in the related press release, found that the transaction between OTE and Orange Romania for the sale of the 54% stake OTE holds in TKR, as initially notified, would have raised serious competition concerns on the market for retail mobile telecommunications services. In particular, Orange would have acquired TKR's 30% minority shareholding in Telekom Romania Mobile Communications S.A (TKRM), one of its key competitors in the Romanian mobile market.

In order to address the aforementioned competition concerns, the parties committed to secure the divestment of TKR's 30% stake in TKRM to OTE, which currently holds 70% of TKRM. The EC has concluded that the proposed transaction, subject to the completion of the aforementioned remedy, would no longer raise competition concerns.

 

2) As announced on July 28, 2021, OTE intends to acquire this 30% stake from TKR subject to required approvals. Such acquisition would increase OTE's stake in TKRM to 99.99%, from 70% currently. The timetable of executing this acquisition will depend on EC approval both of OTE as a suitable purchaser and the divestment agreement. The consideration will be determined following a valuation to be performed by independent advisors. It is not expected to differ significantly from the net book value. OTE discloses relevant financial information on TKRM in its Annual Financial Statements:

https://www.cosmote.gr/otegroup_company/annualreport/2020/en/docs/FinancialReport2020English.pdf 

 

3) TKR divestment of its 30% stake in TKRM will have no impact on the agreed consideration, as announced on November 9, 2020, for the sale of 54% stake OTE holds in TKR to Orange Romania. Proceeds of the 30% sale will be added to TKR's balances and used in the ordinary course. Furthermore, the acquisition of this stake by OTE will have no material impact on the financial position of the Company. The net proceeds to OTE, after the cost of acquiring this 30%, transaction expenses, and required adjustments, will be returned to OTE shareholders in the form of extraordinary dividend and share buybacks as it has been already announced.

 

4) In conformity with all applicable legislation and regulation, the Company will make all necessary announcements to the investor community if and when relevant.

 

 

The European Commission's relevant Press Release is available on the below link:

Ø https://ec.europa.eu/commission/presscorner/detail/en/IP_21_3941

OTE's relevant announcements are available on the below link:

Ø https://www.cosmote.gr/cs/otegroup/en/nea_ependitikes_sxeseis.html

 

 

FOR FURTHER INFORMATION:

OTE GROUP INVESTOR RELATIONS

Tel.: +30 210 6118190

E-mail: iroffice@ote.gr

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPWPUBGMUPGURU
Date   Source Headline
14th Jul 20239:29 amRNSCancellation & Deletion of Own Shares
14th Jul 20238:45 amRNSPurchase of Own Shares
13th Jul 20233:44 pmRNSAnnouncement-absorption of COSMOTE by OTE
7th Jul 20238:25 amRNSPurchase of Own Shares
3rd Jul 20234:23 pmRNSAnnouncement-Dividend Distribution of FY 2022
3rd Jul 202311:32 amRNSRelease Date of Q2/2023 Results
30th Jun 20238:04 amRNSPurchase of Own Shares
23rd Jun 20238:14 amRNSPurchase of Own Shares
22nd Jun 20233:56 pmRNSAnnouncement of Regulated Information - Bond Issue
16th Jun 20238:19 amRNSPurchase of Own Shares
12th Jun 20231:26 pmRNSVoting Results of OTE AGM
9th Jun 20239:09 amRNSPurchase of Own Shares
7th Jun 20233:53 pmRNSResolutions of OTE AGM June 07, 2023
2nd Jun 20238:33 amRNSPurchase of Own Shares
26th May 20239:08 amRNS(Correct Repetition) Purchase of Own Shares
26th May 20238:07 amRNSPurchase of Own Shares
19th May 20238:22 amRNSPurchase of Own Shares
17th May 20233:57 pmRNSInvitation to the 71st AGM
12th May 20237:44 amRNSPurchase of Own Shares
5th May 202310:16 amRNSPurchase of Own Shares
5th May 20238:32 amRNSAnnouncement-Q12023 Financial Results
2nd May 202310:50 amRNSAnnouncement-change of CEO in TKRM
28th Apr 20238:03 amRNSPurchase of Own Shares
21st Apr 20238:11 amRNSPurchase of own shares
12th Apr 20231:12 pmRNSPurchase of Own Shares
6th Apr 202311:31 amRNSPurchase of Own Shares
5th Apr 202310:12 amRNSRelease Date of Q1 2023 Results
31st Mar 20238:24 amRNSPurchase of Own Shares
23rd Mar 20233:40 pmRNSAnnouncement-Purchase of own shares
17th Mar 20238:08 amRNSPurchase of own shares
10th Mar 20238:28 amRNSPurchase of Own Shares
7th Mar 20239:30 amRNSPurchase of own shares
2nd Mar 202311:01 amRNSAnnouncement of regulated information
24th Feb 20238:57 amRNSAnnouncement - Own Share Buyback Intention
23rd Feb 20239:17 amRNSPress Release Q4'2022 Results
10th Feb 202310:31 amRNSAnnouncement of regulated information
24th Jan 202311:44 amRNSFinancial Calendar 2023
23rd Jan 202310:15 amRNSRelease Date Of Q4 2022 Financial Results
9th Dec 202212:34 pmRNSPurchase of own shares
9th Dec 202212:33 pmRNSPurchase of own shares
8th Dec 20222:55 pmRNSAnnouncement of regulated information
29th Nov 202210:25 amRNSAnnouncement of Regulated Information
29th Nov 20228:41 amRNSPurchase of own shares
25th Nov 20229:00 amRNSCancellation & Deletion of own shares
22nd Nov 20228:11 amRNSPurchase of own shares
15th Nov 20229:18 amRNSPurchase of own shares
11th Nov 20221:48 pmRNSAnnouncement of regulated information
10th Nov 20228:16 amRNS3rd Quarter Results 2022
9th Nov 20229:43 amRNSPurchase of own shares
4th Nov 20222:40 pmRNSEGM Voting Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.